Talquetamab: A promising immunotherapy for multiple myeloma

被引：2

作者：

Tariq, Amna ^{[1
]}

Wahid, Abdul ^{[2
,3
]}

Asif, Fatima ^{[2
]}

Khan, Mahnoor ^{[2
]}

机构：

[1] Jinnah Sindh Med Univ, Karachi, Pakistan

[2] Karachi Med & Dent Coll, Karachi, Pakistan

[3] Karachi Med & Dent Coll, North Nazimabad Block M, Karachi 75400, Pakistan

来源：

RARE TUMORS | 2023年 / 15卷

关键词：

D O I：

10.1177/20363613231211051

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：2

共 5 条

[1] The Role of Bispecific Antibodies in Relapsed Refractory Multiple Myeloma: A Systematic Review [J].

Khanam, Razwana ;

Ashruf, Omer S. ;

Bin Waqar, Syed Hamza ;

Shah, Zunairah ;

Batool, Saba ;

Mehreen, Rameesha ;

Pachika, Pranali ;

Roksana, Zinath ;

Rehman, Mohammad Ebad Ur ;

Anwer, Faiz .

ANTIBODIES, 2023, 12 (02)

[2] Bispecific Monoclonal Antibodies in Multiple Myeloma: Data from ASH 2022: A Podcast [J].

Landgren, Ola ;

Nadeem, Omar .

ADVANCES IN THERAPY, 2023, 40 (08) :3291-3303

[3] Bi- and trispecific immune cell engagers for immunotherapy of hematological malignancies [J].

Tapia-Galisteo, Antonio ;

alvarez-Vallina, Luis ;

Sanz, Laura .

JOURNAL OF HEMATOLOGY & ONCOLOGY, 2023, 16 (01)

[4]

van de Donk NW., 2023, Curr Opin Oncol, V36(6), P10

[5] Preclinical activity and determinants of response of the GPRC5DxCD3 bispecific antibody talquetamab in multiple myeloma [J].

Verkleij, Christie P. M. ;

Broekmans, Marloes E. C. ;

van Duin, Mark ;

Frerichs, Kristine A. ;

Kuiper, Rowan ;

de Jonge, A. Vera ;

Kaiser, Martin ;

Morgan, Gareth ;

Axel, Amy ;

Boominathan, Rengasamy ;

Sendecki, Jocelyn ;

Wong, Amy ;

Verona, Raluca, I ;

Sonneveld, Pieter ;

Zweegman, Sonja ;

Adams, Homer C., III ;

Mutis, Tuna ;

van de Donk, Niels W. C. J. .

BLOOD ADVANCES, 2021, 5 (08) :2196-2215

← 1 →